Pre-IND/
Development
Customized service
Efficient production / project management
Positive communication and updates
Quality & cost-driven process innovation
Established technology platforms
Efficient evaluation, costing and quotation system
On time and full delivery of in-specification products
Active after-sale service
Effective safety management systems
Green production concept
Sustainability / Social responsibility
Enquiry to project rate is >70%.
More than 5,000 enquiries received.
Projects with top 20 global pharmaceutical companies.
Providing commercialized product to >50% of them.
40% of revenue from CDMO business.
In FY 2022, revenue increased by 50% compared with 2021.
More than 95% of projects successfully delivered, with >90% delivered on time and in full. Low rate of customer complaints.
Commercial products
Products enter Phase III drug
Products enter Phase I/II drugs
Products enter Preclinical drugs
Broad technology platforms with
intellectual property protection.
More than 15 years’ experience in
CDMO business,
cost-efficient synthetic route design.
Manufacturing site with first class quality systems,
integrated supply chain, continuous production capacity.
Commercial production of a wide range of chiral alcohols, α- and β-amino acids, chiral amines and heterocyclic compounds.
Evaluation from a US based customer:
"One of the best advanced intermediate
manufacturing sites in China".
Striving for superior quality and EHS,
excellent customer service and communication